Injectable lenacapavir (YeztugoⓇ) is a new twice-yearly long-acting injectable form of HIV PrEP that is >99% effective for preventing sexual transmissions of HIV in all genders. This training, led by a Medical Scientist and Nurse Educator team from Gilead Sciences (YeztugoⓇ manufacturer), will provide an overview of injectable lenacapavir prescribing and administration, alongside a detailed … Continued
